On the afternoon of February 24, Shi Yuanyuan, chairman of Shenzhen Cell Valley, Wang Jianxun, chief scientist, Tang Xiaomeng, Deputy general manager, Tang Hui, head of the Ministry of Commerce, Jia Haitao, precision medicine expert, Fu Yuchen, assistant chairman of the Board, and Sun Rui, Minister of the Marketing Department went to Pingshan Central Hospital to visit and exchange. Pingshan Central Hospital President Yang Yifeng, Vice president Li Jin, Vice President Xia Liangwei and other hospital leaders and heads of departments warmly received, the two sides held a symposium in the hospital conference center.

At the beginning of the meeting, Xia Liangwei, vice president of Pingshan Central Hospital, gave a detailed introduction to the overall situation of the hospital. The hospital is large in scale, equipped with advanced medical facilities and comfortable medical environment. The department is fully set up, covering a number of key specialty areas, to provide patients with a full range of medical services. President Yang Yifeng said that in terms of medical technology, the hospital has introduced a number of discipline leaders and well-known clinical experts from Xiangya Medical College, and has worked closely with Xiangya Second Hospital to achieve the goal of supplementing the shortcomings of Pingshan District's medical services, strengthening the grassroots, building high ground and showing its characteristics through the "three translation" of high-end medical brands, technology and personnel.



Professor Shi Yuanyuan, chairman of Shenzhen Cell Valley, introduced the company's progress in the field of cell therapy. Shenzhen Cell Valley has made significant breakthroughs in the core technology of cell therapy, covering the preliminary preparation, quality control process and clinical application. The company has achieved fruitful research and development results, many projects are at the forefront of the industry, and clinical application cases are outstanding, successfully helping many patients to alleviate their conditions and improve their quality of life. The return visit to the hospital aims to further deepen cooperation, accelerate the landing and promotion of cell therapy technology in clinical application by integrating the advantages of both hospitals and enterprises.



Subsequently, the two sides conducted in-depth discussions on the development of universal cell therapy products and the application of relapsed refractory diseases. For more than two hours, Sun Junzhong, Director of Oncology, Wang Qunwei, Director of Major surgery, Liu Xintong, Director of Neurology, Li Xiang, Director of Urology, Liu Minghui, Director of Medical Imaging, Yanchunhua, director of Geriatric Medicine, Li Chaoyang, director of Sleep Center, Tan Zhiping, director of Central Laboratory and other well-known experts from all over the country had practical and effective discussions with the Cell Valley team. Chairman Shi Yuan said that he was very shocked that Pingshan Central Hospital, a brand new hospital with many national clinical experts, was also very lucky to be only one kilometer away from the hospital. Under the leadership of President Yang and other medical experts, Pingshan Central Hospital will soon become a medical highland in the east of Shenzhen. Shenzhen Cell Valley will rely on the technology accumulation and innovation ability in the field of cell therapy to provide Pingshan Central Hospital with the full chain support from research and development to application. Through the clinical practice platform of the linkage hospital and the professional medical team, we will work together to help build the regional cell therapy demonstration center.



After the meeting, the Shenzhen Cell Valley team, accompanied by President Yang Yifeng, visited the outpatient hall, inpatient building, central laboratory and other key departments and facilities of Pingshan Central Hospital to further understand the comprehensive strength of the hospital. Through exchanges and visits, the two sides reached a cooperative intention to promote the Pingshan cell therapy industry and clinical applications. In the future, the two parties will work closely to accelerate the clinical transformation of cell therapy technology, provide patients with better medical services, and promote the high-quality development of the cell therapy industry.



 

Take a group photo